The Role of Glucagon in Cardiac Therapy
- 30 September 1971
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 285 (14) , 801-802
- https://doi.org/10.1056/nejm197109302851414
Abstract
Until recently, glucagon has been of primary interest only to the endocrinologist and biochemist. As a polypeptide hormone produced by the alpha cells of the pancreas, its primary physiologic role appears to be related to the maintenance of glucose levels in the blood. Thus, it acts primarily in the liver by activating adenyl cyclase activity, which promotes the formation of cyclic AMP from ATP. Cyclic AMP, in turn, activates phosphorylase and promotes glycogenolysis. Although it has been known for more than a decade that pharmacologic doses of glucagon have cardiovascular actions, it has only been in the last three or . . .Keywords
This publication has 5 references indexed in Scilit:
- Hemodynamic Evaluation of Glucagon in Symptomatic Heart DiseaseCirculation, 1971
- Acute myocardial infarction in manThe American Journal of Cardiology, 1971
- The effect of glucagon on arrhythmias due to digitalis toxicityThe American Journal of Cardiology, 1970
- Adenyl Cyclase and Myocardial ContractilityAnnals of Internal Medicine, 1970
- Cardiovascular Effects of Glucagon in ManNew England Journal of Medicine, 1968